Author Question: Which of the following is NOT a type of development project? A) Derivative. B) Platform. C) ... (Read 80 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
Which of the following is NOT a type of development project?
 A) Derivative.
  B) Platform.
  C) Breakthrough.
  D) Research and development.
  E) Market capital.

Question 2

Which of the following characteristics is true of induced strategic behavior?
 A) Communication is consistent with organizational flow.
  B) An informal network assesses technical and market merit.
  C) An individual manager defines a market need that diverges from the organization's concept of strategy.
  D) All of the answer choices.



lkanara2

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

E

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library